Who owns OCUPHIRE PHARMA INC?
- Ticker: OCUP
- CUSIP Number: 67577r102
Tip: Access positions for across all investors
Analyze quarterly positions in Ocuphire Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ocuphire Pharma stock
Who bought or sold OCUPHIRE PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 992k | $1.5M | 0% | Jun 2024 |
|
| Geode Capital Management | 272k | $357k | 2% | Sep 2024 |
|
| Bridgeway Capital Management | 164k | $251k | -22% | Jun 2024 |
|
| Richmond Brothers | 156k | $204k | -19% | Sep 2024 |
|
| BlackRock | 109k | $143k | 100% | Sep 2024 |
|
| BlackRock | 107k | $164k | 11% | Jun 2024 |
|
| Citadel Advisors | 102k | $133k | 462% | Sep 2024 |
|
| Knoll Capital Management | 100k | $131k | 0% | Sep 2024 |
|
| Renaissance Technologies | 71k | $93k | 69% | Sep 2024 |
|
| State Street Corporation | 71k | $108k | 0% | Jun 2024 |
|
| Morgan Stanley | 56k | $86k | 0% | Jun 2024 |
|
| Susquehanna International | 50k | $65k | 7% | Sep 2024 |
|
| Kestra Private Wealth Services | 42k | $56k | 0% | Sep 2024 |
|
| Empowered Funds | 41k | $54k | 5% | Sep 2024 |
|
| William Blair $ Company | 33k | $44k | 0% | Sep 2024 |
|
| Diametric Capital | 33k | $44k | -13% | Sep 2024 |
|
| Trust Co Of Toledo Na | 31k | $41k | 0% | Sep 2024 |
|
| Brian McDonald | 30k | $39k | 0% | Sep 2024 |
|
| Northern Trust | 27k | $36k | -47% | Sep 2024 |
|
| Captrust Financial Advisors | 18k | $24k | 0% | Sep 2024 |
|
| Bedel Financial Consulting | 15k | $20k | 0% | Sep 2024 |
|
| Advisor Group Holdings | 14k | $18k | -16% | Sep 2024 |
|
| Stokes Family Office | 12k | $16k | 0% | Sep 2024 |
|
| Raymond James & Associates | 12k | $15k | 100% | Sep 2024 |
|
| Commonwealth Equity Services | 12k | $15k | 100% | Sep 2024 |
|
| Tower Research Capital | 3.6k | $5.5k | -51% | Jun 2024 |
|
| Wells Fargo & Company | 2.8k | $3.7k | 0% | Sep 2024 |
|
| National Bank Of Canada /fi/ | 2.0k | $2.6k | -83% | Sep 2024 |
|
| Barclays | 1.9k | $2.0k | 100% | Sep 2024 |
|
| Eastern Bank | 1.0k | $1.3k | 100% | Sep 2024 |
|
| CarsonAllaria Wealth Management | 1.0k | $1.3k | 0% | Sep 2024 |
|
| Bank of America Corporation | 202.00 | $265.003800 | -5% | Sep 2024 |
|
| Harbour Investments | 40.00 | $52.000000 | 0% | Sep 2024 |
|
| Royal Bank of Canada | 5.00 | $0 | -100% | Sep 2024 |
|
| FSA Wealth Management | 5.00 | $7.000000 | 0% | Sep 2024 |
|
| Proequities | 0 | $0 | -100% | Sep 2024 |
|
Who sold out of Ocuphire Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Rice Hall James & Associates | Jun 2024 | 224k | $342k |
| Jane Street | Jun 2024 | 42k | $65k |
| Virtu Financial | Mar 2024 | 18k | $36k |
| Simplex Trading | Jun 2024 | 1.3k | $2.0k |
| Group One Trading | Jun 2024 | 76.00 | $115.998800 |
| Rhumbline Advisers | Jun 2024 | 26.00 | $39.000000 |
| ICA Group Wealth Management | Mar 2024 | 10.00 | $20.000000 |